Unprecedented Access to Experimental Obesity Drug Raises Questions
The granting of special access to an experimental obesity drug for an unidentified individual is an unusual occurrence that prompts scrutiny.
Editorial Staff about 18 hours ago
3 articles tagged with "obesity"
The granting of special access to an experimental obesity drug for an unidentified individual is an unusual occurrence that prompts scrutiny.
The landscape of obesity medications is evolving, with new drugs entering the market and peptides gaining traction in treatment protocols. The FDA's decisions will be pivotal.
Goat’s rue, a wild plant known for its beauty, has played a significant role in the development of metformin, a key medication for diabetes and obesity, without the adverse effects.